The anti-inflammatory potential of diet and nonalcoholic fatty liver disease: the ATTICA study.

Abstract:

Background:Nonalcoholic fatty liver disease (NAFLD) is correlated with low-grade inflammation and dietary habits. Until today, there have been limited epidemiologic data assessing the role of diet's inflammatory potential on NAFLD. The aim was to evaluate the relationship between an anti-inflammatory diet, as reflected by the Dietary Anti-Inflammation Index (D-AII), and NAFLD among cardiovascular disease (CVD)-free adults. Methods:ATTICA is a prospective, population-based study that recruited 3042 adults without pre-existing CVD from the Greek population (Whites; age ⩾18 years; 1514 men and 1528 women). D-AII was calculated using a standard procedure. The baseline study captured various sociodemographic, lifestyle and clinical characteristics as well as hepatic markers. These were used to calculate four NAFLD assessment indices: triglyceride-glucose (TyG) index, fatty liver index (FLI), hepatic steatosis index (HSI), and NAFLD Fatty Liver Score (NAFLD-FLS). Specific cutoffs were applied to capture NAFLD. Results:D-AII showed a significant inverse association with NAFLD, applying the four indices with NAFLD cutoffs [odds ratio (OR) with 95% confidence interval (CI); TyG (0.95, 0.93-0.98); HSI (0.89, 0.86-0.92); FLI (0.88, 0.85-0.91); NAFLD-FLS (0.89, 0.86-0.92)], after adjusting for various confounders. Participants in the highest D-AII tertile had lower odds of having NAFLD, compared with those in the lowest D-AII tertile [(OR, 95% CI); TyG (0.33, 0.24-0.47); HSI (0.13, 0.08-0.23); FLI (0.05, 0.02-0.11); NAFLD-FLS (0.13, 0.07-0.23)]. Anti-inflammatory nutrition was related to lower odds of NAFLD among daily alcohol drinkers and individuals with metabolic syndrome. Conclusions:Anti-inflammatory diet is an important predictor of NAFLD among adults without pre-existing CVD. Adherence to a high anti-inflammatory diet seems to contribute to NAFLD prevention.

authors

Tyrovolas S,Panagiotakos DB,Georgousopoulou EN,Chrysohoou C,Skoumas J,Pan W,Tousoulis D,Pitsavos C

doi

10.1177/1756284819858039

subject

Has Abstract

pub_date

2019-06-23 00:00:00

pages

1756284819858039

eissn

1756-283X

issn

1756-2848

pii

10.1177_1756284819858039

journal_volume

12

pub_type

杂志文章
  • Prolonged efficacy of pembrolizumab in a patient presenting a multi-treated metastatic hepatocholangiocarcinoma.

    abstract:Introduction:Hepatocholangiocarcinoma (HCC-ICC) is a rare tumor presenting the histologic characteristics of both hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC). As there is no consensus on it management, the therapeutic strategy rests on the specific treatments for HCC or ICC. Programmed cell...

    journal_title:Therapeutic advances in gastroenterology

    pub_type:

    doi:10.1177/1756284820935189

    authors: Saint A,Benchetrit M,Novellas S,Ouzan D,Falk AT,Leysalle A,Barriere J

    更新日期:2020-06-20 00:00:00

  • Pancreatic neuroendocrine tumors: approach to treatment with focus on sunitinib.

    abstract::Pancreatic neuroendocrine tumors (pNETs) are relatively rare malignancies. With secretory tumors such as insulinomas, vasoactive intestinal peptideomas, and gastrinomas, the hormone produced causes the symptom complex (e.g. hypoglycemia, peptic ulcer disease). With nonsecretory NETs, the clinical condition is determin...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章

    doi:10.1177/1756283X13493878

    authors: Vinik AI,Raymond E

    更新日期:2013-09-01 00:00:00

  • Efficacy and safety of adalimumab in Chinese patients with moderately to severely active Crohn's disease: results from a randomized trial.

    abstract:Background and Aims:Efficacy of adalimumab in Crohn's disease (CD) has not been shown in China. The aim of this study was to evaluate the efficacy and safety of adalimumab in Chinese patients with CD. Methods:This 26-week, multicenter, phase III study evaluated patients with moderately to severely active CD and elevat...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章

    doi:10.1177/1756284820938960

    authors: Chen B,Gao X,Zhong J,Ren J,Zhu X,Liu Z,Wu K,Kalabic J,Yu Z,Huang B,Kwatra N,Doan T,Robinson AM,Chen MH

    更新日期:2020-07-16 00:00:00

  • Optimal use of biologics in the management of Crohn's disease.

    abstract::Crohn's disease (CD) is a chronic relapsing and remitting disorder of the gastrointestinal tract with no known cure. The inflammation that drives the disease can lead to debilitating symptoms and a number of complications that may lead to surgery. The introduction of biologic therapy a decade ago has offered a new opt...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章

    doi:10.1177/1756283X09357579

    authors: Panaccione R,Ghosh S

    更新日期:2010-05-01 00:00:00

  • Hereditary pancreatitis for the endoscopist.

    abstract::Hereditary pancreatitis shares a majority of clinical and morphologic features with chronic alcoholic pancreatitis, but may present at an earlier age. The term hereditary pancreatitis has primarily been associated with mutations in the serine protease 1 gene (PRSS1) which encodes for cationic trypsinogen. PRSS1 mutati...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章

    doi:10.1177/1756283X12467565

    authors: Patel MR,Eppolito AL,Willingham FF

    更新日期:2013-03-01 00:00:00

  • Clinical impact of dual red imaging in colorectal endoscopic submucosal dissection: a pilot study.

    abstract:BACKGROUND:Dual red imaging (DRI), a novel image-enhanced endoscopic technique, is expected to improve visibility of thin vessels, but no reports of the clinical use of DRI in colorectal endoscopic submucosal dissection (ESD) have been published. We aimed to compare the visibility of vessels, demarcation line between t...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章

    doi:10.1177/1756283X16645501

    authors: Ninomiya Y,Oka S,Tanaka S,Hirano D,Sumimoto K,Tamaru Y,Asayama N,Shigita K,Nishiyama S,Hayashi N,Chayama K

    更新日期:2016-09-01 00:00:00

  • Effective treatment of chronic radiation proctitis using radiofrequency ablation.

    abstract::Endoscopic argon plasma coagulation and bipolar electrocautery are currently preferred treatments for chronic radiation proctitis, but ulcerations and strictures frequently occur. Radiofrequency ablation (RFA) has been successful for mucosal ablation in the esophagus. Here we report the efficacy of RFA with the BarRx ...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章

    doi:10.1177/1756283x08103341

    authors: Zhou C,Adler DC,Becker L,Chen Y,Tsai TH,Figueiredo M,Schmitt JM,Fujimoto JG,Mashimo H

    更新日期:2009-01-01 00:00:00

  • The potential role of comprehensive genomic profiling to guide targeted therapy for patients with biliary cancer.

    abstract::Remarkable advancements in techniques of genomic profiling and bioinformatics have led to the accumulation of vast amounts of knowledge on the genomic profiles of biliary tract cancer (BTC). Recent largescale molecular profiling studies have not only highlighted genomic differences characterizing tumors of the intrahe...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章,评审

    doi:10.1177/1756283X17698090

    authors: Lee H,Ross JS

    更新日期:2017-06-01 00:00:00

  • Sex-based differences in inflammatory bowel diseases: a review.

    abstract::Sex-based differences in inflammatory bowel disease (IBD) pathogenesis, disease course, and response to therapy have been increasingly recognized, however, not fully understood. Experimental and translational models have been leveraged to investigate hypothesized mechanisms for these observed differences, including th...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章,评审

    doi:10.1177/1756284820915043

    authors: Rustgi SD,Kayal M,Shah SC

    更新日期:2020-04-28 00:00:00

  • Tools for the tract: understanding the functionality of the gastrointestinal tract.

    abstract::The human gastrointestinal tract comprises a series of complex and dynamic organs ranging from the stomach to the distal colon, which harbor immense microbial assemblages that are known to be vital for human health. Until recently, most of the details concerning our gut microbiota remained obscure. Over the past sever...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章

    doi:10.1177/1756283X09337646

    authors: Kovatcheva-Datchary P,Zoetendal EG,Venema K,de Vos WM,Smidt H

    更新日期:2009-07-01 00:00:00

  • EUS-guided FNA for biliary disease as first-line modality to obtain histological evidence.

    abstract:BACKGROUND:Few reports have described endoscopic ultrasound (EUS)-guided fine needle aspiration (FNA) for biliary lesions. In addition, adverse events were not completely examined in previous reports, due to the inclusion of cases in which biliary stents had already been placed. The present study aimed to investigate t...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章

    doi:10.1177/1756283X15625584

    authors: Onda S,Ogura T,Kurisu Y,Masuda D,Sano T,Takagi W,Fukunishi S,Higuchi K

    更新日期:2016-05-01 00:00:00

  • Combined radiological-endoscopic management of difficult bile duct stones: 18-year single center experience.

    abstract:OBJECTIVES:Clinical evidence regarding radiological-endoscopic management of intrahepatic bile duct stones is currently lacking. Our aim is to report our 18-year experience in combined radiological-endoscopic management of intrahepatic difficult bile duct stones. METHODS:From June 1994 to June 2012, 299 symptomatic pa...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章

    doi:10.1177/1756283X15587483

    authors: Cannavale A,Bezzi M,Cereatti F,Lucatelli P,Fanello G,Salvatori FM,Fanelli F,Fiocca F,Donatelli G

    更新日期:2015-11-01 00:00:00

  • Prevalence of end of treatment RNA-positive/sustained viral response in HCV patients treated with sofosbuvir combination therapies.

    abstract:BACKGROUND:Some chronic hepatitis C virus (HCV), genotype 1 infected patients treated with direct antiviral agents (DAAs) remain viremic at end of treatment (EOT+), yet go on to achieve sustained virological response 12 weeks after completion of therapy (SVR12). The incidence of EOT+/SVR in patients with genotype 1 and...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章

    doi:10.1177/1756283X16672392

    authors: Malespin M,Benyashvili T,Uprichard SL,Perelson AS,Dahari H,Cotler SJ

    更新日期:2017-01-01 00:00:00

  • Tryptase mast cell density, protease-activated receptor-2 microvascular density, and classical microvascular density evaluation in gastric cancer patients undergoing surgery: possible translational relevance.

    abstract:BACKGROUND:Mast cells (MCs) can stimulate angiogenesis, releasing several proangiogenic cytokines stored in their cytoplasm. In particular, MCs can release tryptase, a potent in vivo and in vitro proangiogenic factor via protease-activated receptor-2 (PAR-2) activation and mitogen-activated protein kinase (MAPK) phosph...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章

    doi:10.1177/1756283X16673981

    authors: Ammendola M,Sacco R,Vescio G,Zuccalà V,Luposella M,Patruno R,Zizzo N,Gadaleta C,Marech I,Ruggieri R,Kocak IF,Ozgurtas T,Gadaleta CD,Sammarco G,Ranieri G

    更新日期:2017-04-01 00:00:00

  • The intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease?

    abstract::Gut microbiota is a compilation of microorganisms dwelling in the entire mammalian gastrointestinal tract. They display a symbiotic relationship with the host contributing to its intestinal health and disease. Even a slight fluctuation in this equipoise may be deleterious to the host, leading to many pathological cond...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章

    doi:10.1177/1756283X12454590

    authors: Bien J,Palagani V,Bozko P

    更新日期:2013-01-01 00:00:00

  • Eradication of helicobacter pylori to prevent gastroduodenal diseases: hitting more than one bird with the same stone.

    abstract::Helicobacter pylori (H. pylori) are gram-negative bacteria that selectively colonizes the gastric mucosa. The prevalence of H. pylori infection varies from 20 to 50% in industrialized countries to over 80% in developing countries. The infection may persist lifelong without specific treatment. Prolonged infection and i...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章

    doi:10.1177/1756283X08094880

    authors: Lee YC,Liou JM,Wu MS,Wu CY,Lin JT

    更新日期:2008-09-01 00:00:00

  • Cost savings following faecal microbiota transplantation for recurrent Clostridium difficile infection.

    abstract:Background:Recurrent Clostridium difficile infection (rCDI) is becoming increasingly common. Faecal microbiota transplantation (FMT) is effective for rCDI, but the costs of an FMT and hospital cost savings related to FMT are unknown. The aim of this study was to calculate the cost of an FMT and the total hospital costs...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章

    doi:10.1177/1756284819843002

    authors: Dehlholm-Lambertsen E,Hall BK,Jørgensen SMD,Jørgensen CW,Jensen ME,Larsen S,Jensen JS,Ehlers L,Dahlerup JF,Hvas CL

    更新日期:2019-04-10 00:00:00

  • Review of the epidemiology and burden of ulcerative colitis in Latin America.

    abstract::The incidence and prevalence of ulcerative colitis (UC) has been reported to be rising in newly industrialised regions, such as Latin America. Here, we review data from published studies reporting demographics and clinical aspects of UC in Latin America to further understand epidemiology and disease burden. The incide...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章,评审

    doi:10.1177/1756284820931739

    authors: Kotze PG,Steinwurz F,Francisconi C,Zaltman C,Pinheiro M,Salese L,Ponce de Leon D

    更新日期:2020-07-09 00:00:00

  • Predicting durable response or resistance to antitumor necrosis factor therapy in inflammatory bowel disease.

    abstract::Monoclonal antibodies to tumor necrosis factor (TNF) have become a mainstay of the therapeutic armamentarium in inflammatory bowel disease (IBD) over the last 15 years. Although highly effective, primary and secondary nonresponse are common and associated with poor clinical outcomes and significant costs. Multiple cli...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章,评审

    doi:10.1177/1756283X16638833

    authors: Kopylov U,Seidman E

    更新日期:2016-07-01 00:00:00

  • Incidence of Clostridioides difficile infection in peripartum women: a retrospective cohort study.

    abstract:Background:The incidence of Clostridioides difficile infection (CDI) is increasing in the general population. Data on the epidemiology of CDI in peripartum women - a highly vulnerable patient population - is scarce. The objective of this study was to report the incidence of CDI in peripartum women. Methods:A single-ce...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章

    doi:10.1177/1756284820942621

    authors: Saha S,Pardi R,Theiler RN,Pardi DS,Khanna S

    更新日期:2020-07-27 00:00:00

  • Novel cytokine signaling pathways in inflammatory bowel disease: insight into the dichotomous functions of IL-33 during chronic intestinal inflammation.

    abstract::In 2010, four independent groups almost simultaneously reported the association of the novel interleukin-1 (IL-1) family member, IL-33, with inflammatory bowel disease (IBD). The findings were remarkably consistent and demonstrated that IL-33 is markedly upregulated in, and specific to, ulcerative colitis (UC). In add...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章

    doi:10.1177/1756283X11410770

    authors: Pastorelli L,De Salvo C,Cominelli MA,Vecchi M,Pizarro TT

    更新日期:2011-09-01 00:00:00

  • Antagonizing programmed death-1 and programmed death ligand-1 as a therapeutic approach for gastric cancer.

    abstract::Malignant tumor cells are equipped with mechanisms that can help them escape the surveillance by host immune system. Immune checkpoint molecules can transduce coinhibitory signals to immunocompetent cells and exert immunosuppressive roles in antitumor immunity. Programmed death-1 (PD-1) and programmed death ligand-1 (...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章,评审

    doi:10.1177/1756283X16658251

    authors: Liu X,Yang Z,Latchoumanin O,Qiao L

    更新日期:2016-11-01 00:00:00

  • Simultaneous analyses of carbohydrate-mediated serum GLP-1 and GLP-2 and duodenal receptor expression in children with and without celiac disease.

    abstract:Background:Variability in glucagon-like peptide (GLP)-1 and GLP-2 plasma concentrations has been suggested in Celiac disease (CD), with inconclusive results. We assessed the association between serum levels of GLP-1 and GLP-2 and their duodenal receptor expression in children with and without CD. Methods:This was a tw...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章

    doi:10.1177/1756284819842756

    authors: Rachmiel M,Ben-Yehudah G,Shirin H,Broide E

    更新日期:2019-04-17 00:00:00

  • Clinical outcome of patients with obscure gastrointestinal bleeding during antithrombotic drug therapy.

    abstract:Background:The clinical outcome of patients with obscure gastrointestinal bleeding (OGIB) during antithrombotic drug therapy has not been fully investigated. Methods:Patients who underwent video capsule endoscopy (VCE) for the investigation of OGIB at Okayama University Hospital from January 2009 to March 2016 were en...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章

    doi:10.1177/1756283X17746930

    authors: Kono Y,Kawano S,Okamoto Y,Obayashi Y,Baba Y,Sakae H,Abe M,Gotoda T,Inokuchi T,Kanzaki H,Iwamuro M,Kawahara Y,Okada H

    更新日期:2018-01-14 00:00:00

  • Challenges and prospects for pharmacotherapy in functional gastrointestinal disorders.

    abstract::Functional gastrointestinal disorders, such as irritable bowel syndrome and functional dyspepsia, are complex conditions with multiple factors contributing to their pathophysiology. As a consequence they are difficult to treat and have posed significant challenges to the pharmaceutical industry when trying to develop ...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章

    doi:10.1177/1756283X10369922

    authors: Sanger GJ,Chang L,Bountra C,Houghton LA

    更新日期:2010-09-01 00:00:00

  • Prophylaxis of hepatitis B infection in solid organ transplant recipients.

    abstract::Rates of transmission of hepatitis B virus (HBV) infection from organ donors with HBV markers to recipients along with reactivation of HBV during immunosuppression following transplantation have fallen significantly with the advent of hepatitis B immune globulin (HBIg) and effective antiviral therapy. Although the ava...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章

    doi:10.1177/1756283X13487942

    authors: John S,Andersson KL,Kotton CN,Hertl M,Markmann JF,Cosimi AB,Chung RT

    更新日期:2013-07-01 00:00:00

  • Erratum for PMID 21180585.

    abstract::Erratum to 'Possible interactions between dietary fibres and 5-aminosalicyclic acid' by C Henriksen, S Hansen, I Nordgaard-Lassen, J Rikardt Anderson and P Madsen. Therapeutic Advances in Gastroenterology (2010) 3(1) 5-9 [DOI: 10.1177/ 1756283X09347810][This corrects the article on p. 5 in vol. 3.]. ...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 已发布勘误

    doi:10.1177/1756283X10363751

    authors:

    更新日期:2012-09-01 00:00:00

  • The changing landscape of hepatitis C virus therapy: focus on interferon-free treatment.

    abstract::Chronic hepatitis C (CHC) affects over 185 million individuals worldwide, approximately 3% of the world's population. CHC can lead to quality of life impairment, cirrhosis, hepatocellular carcinoma (HCC), liver failure and liver-related death. While CHC has been associated with increases in HCC, liver-related mortalit...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章,评审

    doi:10.1177/1756283X15587481

    authors: Lam BP,Jeffers T,Younoszai Z,Fazel Y,Younossi ZM

    更新日期:2015-09-01 00:00:00

  • Automated endoscopic detection and classification of colorectal polyps using convolutional neural networks.

    abstract:Background:Recently the American Society for Gastrointestinal Endoscopy addressed the 'resect and discard' strategy, determining that accurate in vivo differentiation of colorectal polyps (CP) is necessary. Previous studies have suggested a promising application of artificial intelligence (AI), using deep learning in o...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章

    doi:10.1177/1756284820910659

    authors: Ozawa T,Ishihara S,Fujishiro M,Kumagai Y,Shichijo S,Tada T

    更新日期:2020-03-20 00:00:00

  • Targeting neutrophil extracellular traps in severe acute pancreatitis treatment.

    abstract::Severe acute pancreatitis (SAP) is a critical abdominal disease associated with high death rates. A systemic inflammatory response promotes disease progression, resulting in multiple organ dysfunction. The functions of neutrophils in the pathology of SAP have been presumed traditionally to be activation of chemokine a...

    journal_title:Therapeutic advances in gastroenterology

    pub_type: 杂志文章,评审

    doi:10.1177/1756284820974913

    authors: Hu J,Kang H,Chen H,Yao J,Yi X,Tang W,Wan M

    更新日期:2020-11-24 00:00:00